Hikma Pharmaceuticals【HIK】銘柄情報

Hikma Pharmaceuticals Plc (HIK) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

1,531.00

( 0.07% )

買値

1,531.00

売値

1,532.00

出来高

223,708

1,516.00 日の範囲 1,539.00

1,187.00 52 週間の範囲 2,052.00

時価総額

3.261B

前日終値

1,530.00

始値

1,539.00

時刻

1020

1531

(O)

最終取引時間

財務取引量

3,423,364p

VWAP

1,530.2825

平均取引量 (3 か月)

898,882p

発行済株式数

213,030,512

配当利回り

0.84

PER

11.11

1 株当たり利益 (EPS)

1.81

歳入

3.35B

純利益

402M

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. The Injectables segment provides generic and specialty injectable products primari... Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The Hikma Rx segment offers oral, respiratory, and other generic and specialty products for the retail market. It provides its products in various therapeutic areas, including respiratory, oncology, and pain management. The company also offers its products in solid, semi-solid, liquid, and injectable dosage forms. It operates in the United Kingdom, Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, United Kingdom. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

www.hikma.com

本社

London, United Kingdom

設立

1978

Hikma Pharmaceuticals Plc is listed in the Healthcare sector of the ロンドン証券取引所 with ticker HIK. The last closing price for Hikma Pharmaceuticals was 1,530p. Over the last year, Hikma Pharmaceuticals shares have traded in a share price range of 1,187.00p to 2,052.00p.

Hikma Pharmaceuticals currently has 213,030,512 shares in issue. The market capitalisation of Hikma Pharmaceuticals is £3.26 billion. Hikma Pharmaceuticals has a price to earnings ratio (PE ratio) of 11.11.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	111	7.81690140845	1420	1539	1420	966234	1499.12563204	DE
4	38	2.54521098459	1493	1539	1397	875335	1463.5699741	DE
12	231	17.7692307692	1300	1539	1273	823932	1421.2373768	DE
26	3	0.196335078534	1528	1691	1187	1124600	1389.03867128	DE
52	-497	-24.5069033531	2028	2052	1187	888400	1516.38654851	DE
156	-368.5	-19.3998420637	1899.5	2360	1187	613051	1754.30528687	DE
260	-888	-36.709384043	2419	2703	1174.5	605553	1770.32179202	DE